Premium
Biomea Fusion Inc (BMEA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical tria... Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2 | 16.8067226891 | 1.19 | 1.405 | 1.18 | 916963 | 1.25913733 | CS |
| 4 | 0.0192 | 1.4006419609 | 1.3708 | 1.48 | 1.1 | 1008605 | 1.24244471 | CS |
| 12 | -0.14 | -9.15032679739 | 1.53 | 2.237 | 1.1 | 1406142 | 1.57256129 | CS |
| 26 | 0.08 | 6.10687022901 | 1.31 | 2.237 | 1.03 | 1282841 | 1.45442625 | CS |
| 52 | -0.44 | -24.043715847 | 1.83 | 2.99 | 0.8719 | 1354567 | 1.57061359 | CS |
| 156 | -21.17 | -93.8386524823 | 22.56 | 23.92 | 0.8719 | 1166406 | 5.76105919 | CS |
| 260 | -13.61 | -90.7333333333 | 15 | 43.69 | 0.8719 | 814070 | 8.12940155 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
